• Miragen Therapeutics (NASDAQ:MGEN) Lifted to Buy at Zacks Investment Research

    According to Zacks, “Miragen Therapeutics, Inc. is a biopharmaceutical company. It develops microRNA biology, oligonucleotide chemistry, drugs and …

    Read More
  • 0 0